·ï»ËÁªÃË(ÖйúÇø)¡¤¹Ù·½ÍøÕ¾

»¶Ó­·ÃÎʹ㶫º£Ñó´óѧÉÌѧԺ£¡

µ±Ç°Î»ÖÃ: ·ï»ËÁªÃË > µ³½¨Ö®Éù > ¾¯Ê¾½ÌÓý > ÕýÎÄ

¾¯Ê¾½ÌÓý

20¶àÃû¸ßУÈËԱѧÊõ²»¶Ë±»Í¨±¨£¡ÉæÂòÂôÂÛÎÄ¡¢³­Ï®µÈ

ʱ¼ä£º2025-06-14 13:03:58  ×÷ÕߣºÈËÃñÈÕ±¨  ÉóºËÈË£ºÈËÃñÈÕ±¨  ±à¼­£ºÈËÃñÈÕ±¨  µã»÷£º ´Î

½üÆÚ£¬¾­¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»á¼à¶½Î¯Ô±»áµ÷²éÉóÒ飬Óɹú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»áίÎñ»áÒéÉ󶨣¬¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»á¶ÔÏà¹Ø¿ÆÑв»¶Ë°¸¼þÉæÊÂÖ÷Ìå½øÐÐÁË´¦Àí¡£ÏÖ¸ù¾ÝÓйع涨£¬½«¸øÓèͨ±¨ÅúÆÀµÄÔðÈÎÖ÷Ì幫²¼ÈçÏ£º

£¨Ò»£©¾­²é£¬¹ãÎ÷ij¸ßУºØ¾ÛÁ¼µÈ·¢±íµÄÂÛÎÄ¡°Juliang He#, et al. Long noncoding RNA CCDC144NL-AS1 promotes the oncogenicity of osteosarcoma by acting as a molecular sponge for microRNA-490-3p and thereby increasing HMGA2 expression. OncoTargets and Therapy, 2021, 14:1-13.¡±´æÔÚÂòÂôʵÑéÑо¿Êý¾ÝºÍδ¾­Í¬ÒâʹÓÃËûÈËÊðÃûÎÊÌ⣬ÇҺؾÛÁ¼½«¸ÃÂÛÎÄÁÐÈë»ù½ðÏîÄ¿£¨Åú×¼ºÅ82160793£©ÉêÇëÊé¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®¶þÌõµÚ¶þÏî¡¢µÚËÄÊ®ÈýÌõµÚÒ»Ï³·ÏúºØ¾ÛÁ¼¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°¼ä³äÖʸÉϸ°ûÀ´Ô´ÍâÃÚÌå´«µÝLINC00957°ÐÏòµ÷¿ØWT1Ó°Ïì¹ÇÈâÁöϸ°û×ÔÊɼ°×³Ò©¼¦ÑªÌÙÌáÈ¡µ¥ÌåëÈïÒì»ÆÍªµÄ¸ÉÔ¤»úÖÆÑо¿¡±£¨Åú×¼ºÅ82160793£©£¬×·»ØÒѲ¦×ʽð£¬È¡ÏûºØ¾ÛÁ¼¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬¸øÓèºØ¾ÛÁ¼Í¨±¨ÅúÆÀ¡£

£¨¶þ£©¾­²é£¬¼ªÁÖijҽԺÀîÔóµÈ·¢±íµÄÂÛÎÄ¡°Ze Li*, et al. Long Non-Coding RNA C1QTNF1 Antisense RNA 1 Upregulates Hexokinase 2 by Sponging microRNA-484 to Promote the Malignancy of Colorectal Cancer. Cancer Manag Res, 2020, 12:12053-12066.¡±´æÔÚÂòÂôʵÑéÑо¿Êý¾ÝÎÊÌ⣬ÇÒÀîÔ󽫸ÃÂÛÎÄÁÐÈë»ù½ðÏîÄ¿£¨ÉêÇëºÅ8217114340£©ÉêÇëÊé¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®¶þÌõµÚ¶þÏȡÏûÀîÔó¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬¸øÓèÀîÔóͨ±¨ÅúÆÀ¡£

£¨Èý£©¾­²é£¬ºþÄÏij¸ßУÂíãüµÈ·¢±íµÄÂÛÎÄ¡°Hong Ma*, et al. Long Noncoding RNA LINC00525 Promotes the Aggressive Phenotype of Chordoma Through Acting as a microRNA-505-3p Sponge and Consequently Raising HMGB1 Expression. Onco Targets Ther, 2020, 13:9015-9027.¡±´æÔÚÂòÂôʵÑéÑо¿Êý¾ÝÎÊÌ⣬ÇÒÂíãü½«¸ÃÂÛÎÄÁÐÈë»ù½ðÏîÄ¿£¨ÉêÇëºÅ8210115144£©ÉêÇëÊé¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®¶þÌõµÚ¶þÏȡÏûÂíãü¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬¸øÓèÂíãüͨ±¨ÅúÆÀ¡£

£¨ËÄ£©¾­²é£¬¹ã¶«Ä³¸ßУÑîÒ«¡¢Íõ½ø½øÓëÀîÎÄÑåµÈ·¢±íµÄÂÛÎÄ1¡°Yao Yang#, Jinjin Wang, Wenyan Li, et al.. Enhanced biofiltration coupled with ultrafiltration process in marine recirculating aquaculture system: Fast start-up of nitrification and long-term performance. Separation and Purification Technology, 2024, 335, 125795£¨±ê×¢»ù½ðºÅ42077131¡¢41977126£©¡±´æÔÚÂòÂôÂÛÎÄ¡¢Î´¾­Í¬ÒâʹÓÃËûÈËÊðÃû¡¢ÉÃ×Ô±ê×¢ËûÈË¿ÆÑ§»ù½ðÏîÄ¿ÎÊÌ⣻ÂÛÎÄ2¡°Yao Yang, Jinjin Wang, Wenyan Li*, et al.Biological activated carbon filtration controls membrane fouling and reduces by-products from chemically enhanced backwashing during ultrafiltration treatment. Water, 2023, 15£¨21£©, 3803.£¨±ê×¢»ù½ðºÅ41977126¡¢42077131£©¡±´æÔÚÂòÂôÂÛÎÄ¡¢ÔÚÓë¿ÆÑ§»ù½ðÏîÄ¿Î޹صĿÆÑгɹûÖбê×¢»ù½ðÏîÄ¿µÄÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®ÆßÌõ¡¢µÚËÄÊ®¶þÌõµÚ¶þÏî¡¢µÚËÄÊ®ÈýÌõµÚÒ»ÏîºÍµÚÁùÏȡÏûÑîÒ«¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ5Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2029Äê7ÔÂ18ÈÕ£©£¬¸øÓèÑîҫͨ±¨ÅúÆÀ£»ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®ÆßÌõ¡¢µÚËÄÊ®¶þÌõµÚ¶þÏî¡¢µÚËÄÊ®ÈýÌõµÚËÄÏîºÍµÚ°ËÏîµÄ¹æ¶¨£¬È¡ÏûÍõ½ø½ø¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬¸øÓèÍõ½ø½øÍ¨±¨ÅúÆÀ£»ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®ÆßÌõ¡¢µÚËÄÊ®¶þÌõµÚ¶þÏî¡¢µÚËÄÊ®ÈýÌõµÚËÄÏîºÍµÚ°ËÏȡÏûÀîÎÄÑå¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬¸øÓèÀîÎÄÑåͨ±¨ÅúÆÀ¡£

£¨Î壩¾­²é£¬½­Î÷ij¸ßУÖÓÎĺÍÔ¸£²ÆµÈ·¢±íµÄÂÛÎÄ¡°Wen Zhong, Fucai Yue*, et al. Fractal Behavior of Particle Size Distribution in the Rare Earth Tailings Crushing Process under High Stress Condition. Applied Sciences 2018, 8: 1058.£¨±ê×¢»ù½ðºÅ51504102¡¢51764014¡¢51404111£©¡±´æÔÚ³­Ï®ØâÇÔ¡¢Î±Ôì´Û¸Ä¡¢Î´¾­Í¬ÒâʹÓÃËûÈËÊðÃû¡¢ÉÃ×Ô±ê×¢ËûÈË»ù½ðÏîÄ¿ÎÊÌ⣬ÇÒÖÓÎĽ«ÂÛÎÄÁÐÈë»ù½ðÏîÄ¿£¨Åú×¼ºÅ52364014£©ÉêÇëÊé¡¢ÁÐÈë»ù½ðÏîÄ¿£¨Åú×¼ºÅ51764014£©½øÕ¹±¨¸æ¼°»ù½ðÏîÄ¿£¨Åú×¼ºÅ51504102¡¢51764014£©½áÌⱨ¸æ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®ÆßÌõ£¬µÚËÄÊ®Ìõ£¬µÚËÄÊ®ÈýÌõµÚÒ»ÏîºÍµÚÁùÏµÚËÄÊ®ÁùÌõ£¬³·ÏúÖÓÎĹú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°Àë×ÓÐÍÏ¡ÍÁβ¿ó±ßÆÂÖÎÀídz²ãÖ²±»¸ùϵ¹ÌÍÁÁ¦Ñ§ÐÐΪÑо¿¡±£¨Åú×¼ºÅ52364014£©¡¢¡°½þ¿óÇÖÊ´×÷ÓÃÏÂÀë×ÓÐÍÏ¡ÍÁ¿ó´²»ùÑÒºêϸ¹ÛÁÓ»¯»úÖÆÑо¿¡±£¨Åú×¼ºÅ51764014£©¡¢¡°Ô­µØ½þ¿óºóÀë×ÓÐÍÏ¡ÍÁ¿óÌå΢½á¹¹Á¦Ñ§ÌØÐÔÈõ»¯»úÖÆÑо¿¡±£¨Åú×¼ºÅ51504102£©£¬×·»Ø3¸öÏîÄ¿µÄÒѲ¦×ʽð£¬È¡ÏûÖÓÎĹú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬¸øÓèÖÓÎÄͨ±¨ÅúÆÀ£»ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®ÆßÌõ£¬µÚËÄÊ®Ìõ£¬µÚËÄÊ®ÈýÌõµÚÒ»ÏîºÍµÚÁùÏȡÏûÔ¸£²Æ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ5Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2029Äê7ÔÂ18ÈÕ£©£¬¸øÓèÔ¸£²ÆÍ¨±¨ÅúÆÀ¡£

£¨Áù£©¾­²é£¬¹ã¶«Ä³¸ßУ»Æ¹ÚȺµÈ·¢±íµÄÂÛÎÄ1¡° Guanqun Huang#, et al. Long non-coding RNA TPT1-AS1 promotes cell growth and metastasis in cervical cancer via acting AS a sponge for miR-324-5p. J Exp Clin Cancer Res.2018 Jul 25;37(1):169.£¨±ê×¢»ù½ðºÅ81673206£©¡±´æÔÚÂòÂôʵÑéÑо¿Êý¾ÝÎÊÌ⣬ÂÛÎÄ2¡°Guanqun Huang#, et al. LncGPR107 drives the self-renewal of liver tumor initiating cells and liver tumorigenesis through GPR107-dependent manner. J Exp Clin Cancer Res. 2018 Jun 20;37(1):121.£¨±ê×¢»ù½ðºÅ81673206£©¡±´æÔÚͼƬʹÓûìÂÒÎÊÌ⣻ÂÛÎÄ1¡¢2»¹´æÔÚδ¾­Í¬ÒâʹÓöàÈËÊðÃû¡¢ÉÃ×Ô±ê×¢»ù½ðÏîÄ¿×ÊÖúµÈÎÊÌ⣬ÇһƹÚȺ½«ÂÛÎÄ1ºÍÂÛÎÄ2ÁÐÈë»ù½ðÏîÄ¿£¨ÉêÇëºÅ8197110308¡¢8207110324£©ÉêÇëÊé¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®ÆßÌõ£¬µÚËÄÊ®Ìõ£¬µÚËÄÊ®¶þÌõµÚ¶þÏî¡¢µÚÎåÏµÚËÄÊ®ÈýÌõµÚÒ»Ïî¡¢µÚÁùÏȡÏû»Æ¹ÚȺ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ5Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2029Äê7ÔÂ18ÈÕ£©£¬¸øÓè»Æ¹ÚȺͨ±¨ÅúÆÀ¡£

£¨Æß£©¾­²é£¬ÉϺ£Ä³¸ßУÑà¶«ÁÁµÈ·¢±íµÄÂÛÎÄ¡°Dongliang Yan*, et al. FAM46B inhibits cell proliferation and cell cycle progression in prostate cancer through ubiquitination of ¦Â-catenin. Experimental & molecular medicine, 2018.50(12), 1¨C12.¡±´æÔÚÂòÂôʵÑéÑо¿Êý¾ÝÎÊÌ⣬ÇÒÑà¶«ÁÁ½«¸ÃÂÛÎÄÁÐÈë»ù½ðÏîÄ¿£¨ÉêÇëºÅ8197101420£©ÉêÇëÊé¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®¶þÌõµÚ¶þÏȡÏûÑà¶«ÁÁ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬¸øÓèÑà¶«ÁÁͨ±¨ÅúÆÀ¡£

£¨°Ë£©¾­²é£¬ºþ±±Ä³¸ßУÓàÖ¾ºìµÈ·¢±íµÄÂÛÎÄ¡°Zhihong Yu*, et al. Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer. Int J Nanomedicine. 2017;12:6153-6168.£¨±ê×¢»ù½ðºÅ81402434£©¡±ºÍ¡°Zhihong Yu*, et al. Indomethacin-based stimuli-responsive micelles combined with paclitaxel to overcome multidrug resistance. Oncotarget.2017, 8:111281-11294.¡±´æÔÚͼƬαÔì´Û¸ÄºÍδ¾­Í¬ÒâʹÓÃËûÈËÊðÃûÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®ÆßÌõ¡¢µÚËÄÊ®Ìõ¡¢µÚËÄÊ®ÈýÌõµÚÒ»ÏȡÏûÓàÖ¾ºì¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬¸øÓèÓàÖ¾ºìͨ±¨ÅúÆÀ¡£

£¨¾Å£©¾­²é£¬Õ㽭ijÁ½Ëù¸ßУÐì¼Ì¡¢ËιãÔªµÈ·¢±íµÄÂÛÎÄ¡°Guangyuan Song#, Ji Xu*, et al. miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting ERBB4 expression. Oncotarget. 2017, 8(28):45725-45735.¡±´æÔÚͼƬαÔì´Û¸ÄÎÊÌ⣬ÇÒÐì¼Ì½«¸ÃÂÛÎÄÁÐÈë»ù½ðÏîÄ¿£¨ÉêÇëºÅ8180110074¡¢8207101224£©ÉêÇëÊé¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®ÆßÌõ¡¢µÚËÄÊ®Ìõ£¬È¡ÏûÐì¼Ì¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬¸øÓèÐì¼Ìͨ±¨ÅúÆÀ£»ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®ÆßÌõ¡¢µÚËÄÊ®Ìõ£¬È¡ÏûËιãÔª¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬¸øÓèËιãԪͨ±¨ÅúÆÀ¡£

£¨Ê®£©¾­²é£¬ÁÉÄþij¸ßУ·½¾§¾§ÔÚ2024Äê»ù½ðÏîÄ¿ÉêÇë¹ý³ÌÖдæÔÚ³­Ï®ËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈݺÍÌṩÐé¼ÙͬÐÐר¼ÒÍÆ¼öÐÅÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®Ìõ¡¢µÚËÄʮһÌõµÚÈýÏ³·Ïú·½¾§¾§2024Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°»ùÓÚÈýάÉî¶Èѧϰ¼¼ÊõµÄÓñÃ×ȺÌåÐÎ̬½á¹¹½âÎöÓëÈýÎ¬ÖØ½¨·½·¨Ñо¿¡±£¨ÉêÇëºÅ6247076473£©ÉêÇ룬ȡÏû·½¾§¾§¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ5Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2029Äê7ÔÂ18ÈÕ£©£¬¸øÓè·½¾§¾§Í¨±¨ÅúÆÀ¡£

£¨Ê®Ò»£©¾­²é£¬ÉϺ£Ä³¸ßУÁº¾Þ²¨ÔÚ2023Äê»ù½ðÏîÄ¿ÉêÇë¹ý³ÌÖдæÔÚ³­Ï®ËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈݺͳö¾ß²»Êµ³ÂÊöÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®Ìõ£¬³·ÏúÁº¾Þ²¨2023Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°ÐÂÐÍÃâÒß¼ì²éµãSiglec15ͨ¹ýµ÷¿ØËèÔ´ÒÖÖÆÏ¸°ûÔÚ×ÔÉíÃâÒßÐÔ¸ÎÑ×ÃâÒß΢»·¾³µÄ»úÖÆÑо¿£¨ÉêÇëºÅ8230034806£©¡±ÉêÇ룬ȡÏûÁº¾Þ²¨¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇëÏîÄ¿×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬¸øÓèÁº¾Þ²¨Í¨±¨ÅúÆÀ¡£

£¨Ê®¶þ£©¾­²é£¬Ìì½òij¸ßУÕÅÄþÄþÔÚ2024Äê»ù½ðÏîÄ¿ÉêÇë¹ý³ÌÖдæÔÚ³­Ï®ËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈÝÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®Ìõ£¬³·ÏúÕÅÄþÄþ2024Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°¹Ø½ÚÈí¹ÇË¥ÀÏÓëÔÙÉúÐÞ¸´Õϰ­µÄ·Ö×Ó»úÖÆÑо¿¡±£¨ÉêÇëºÅ8240092759£©ÉêÇ룬ȡÏûÕÅÄþÄþ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬¸øÓèÕÅÄþÄþͨ±¨ÅúÆÀ¡£

£¨Ê®Èý£©¾­²é£¬½­ËÕij¸ßУ²Ü¶¶ÔÚ2024Äê»ù½ðÏîÄ¿ÉêÇë¹ý³ÌÖдæÔÚ³­Ï®ËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈÝÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®Ìõ£¬³·Ïú²Ü¶¶2024Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°ÔËÓõ°°×ÖÊ×éѧ̽¾¿ÌæÄªßò°·ÖÎÁÆÄÍÊÜÓ뽺ÖÊÁöÖÐС½ºÖÊϸ°ûµÄ¹ØÏµ¡±£¨ÉêÇëºÅ8240131039£©ÉêÇ룬ȡÏû²Ü¶¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬¸øÓè²Ü¶¶ͨ±¨ÅúÆÀ¡£

£¨Ê®ËÄ£©¾­²é£¬ºÚÁú½­Ä³¸ßУËïç÷ÔÚ2024Äê»ù½ðÏîÄ¿ÉêÇë¹ý³ÌÖдæÔÚ³­Ï®ËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈÝÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®Ìõ£¬³·ÏúËïç÷2024Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°IL-33µ÷¿ØÐ¡½ºÖÊϸ°ûºÍ¾ÞÊÉϸ°û¶Ô¼¹ËèËðÉ˺óËèÇÊÔÙÉúµÄ×÷ÓÃÑо¿¡±£¨ÉêÇëºÅ8240055211£©ÉêÇ룬ȡÏûËïç÷¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬¸øÓèËïç÷ͨ±¨ÅúÆÀ¡£

£¨Ê®Î壩¾­²é£¬½­ËÕij¸ßУÍõ³¿¾¸ÔÚ2023Äê»ù½ðÏîÄ¿ÉêÇë¹ý³ÌÖдæÔÚ³­Ï®ËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈÝÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®Ìõ£¬³·ÏúÍõ³¿¾¸2023Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°STT3a½éµ¼µÄϸ°ûÖ¬ÖʺϳÉÔڽ᳦°©Î÷Í×Îôµ¥¿¹ÄÍÒ©ÖеÄ×÷Óü°Æä»úÖÆÑо¿¡±£¨ÉêÇëºÅ8230131444£©ÉêÇ룬ȡÏûÍõ³¿¾¸¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬¸øÓèÍõ³¿¾¸Í¨±¨ÅúÆÀ¡£

£¨Ê®Áù£©¾­²é£¬ÉϺ£Ä³¸ßУÀî»ÂÕéÔÚ2024Äê»ù½ðÏîÄ¿ÉêÇë¹ý³ÌÖдæÔÚ³­Ï®ËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈÝÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®Ìõ£¬³·ÏúÀî»ÂÕé2024Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°»ùÓÚÉî¶ÈѧϰµÄ¿ÚÇ»ÎÀÉúÖ¸µ¼Æ½Ì¨µÄ¹Ø¼ü¼¼ÊõÑо¿¡±£¨ÉêÇëºÅ8240031006£©ÉêÇ룬ȡÏûÀî»ÂÕé¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬¸øÓèÀî»ÂÕéͨ±¨ÅúÆÀ¡£

£¨Ê®Æß£©¾­²é£¬±±¾©Ä³Ñо¿ÔºÓÐÏÞ¹«Ë¾Ì·ÇåÀ¤ÔÚ2024Äê»ù½ðÏîÄ¿ÉêÇë¹ý³ÌÖдæÔÚ³­Ï®ËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈÝÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®Ìõ£¬³·ÏúÌ·ÇåÀ¤2024Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°Ô°Çø×ÛºÏÄÜÔ´Ìå¶àÄÜЭͬÓÅ»¯Ä£Ðͼ°ÀûÒæÖ÷Ìå¼äЭµ÷¼¤Àø»úÖÆÑо¿¡±£¨ÉêÇëºÅ7247011904£©ÉêÇ룬ȡÏûÌ·ÇåÀ¤¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬¸øÓèÌ·ÇåÀ¤Í¨±¨ÅúÆÀ¡£

£¨Ê®°Ë£©¾­²é£¬É½¶«Ä³¸ßУÆë°®Ñ§ÔÚ2024Äê»ù½ðÏîÄ¿ÉêÇë¹ý³ÌÖдæÔÚ³­Ï®ËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈÝÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®Ìõ£¬³·ÏúÆë°®Ñ§2024Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°»ùÓÚ»ìãç±ßÔµµÄ¾Ö²¿ÓÐÔ´Òä×èÆ÷Éñ¾­Ôª¼°Æä¶¯Á¦Ñ§Ñо¿¡±£¨ÉêÇëºÅ6247013499£©ÉêÇ룬ȡÏûÆë°®Ñ§¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬¸øÓèÆë°®Ñ§Í¨±¨ÅúÆÀ¡£

£¨Ê®¾Å£©¾­²é£¬¹ã¶«Ä³¸ßÐ£ÌÆ½­²¨ÔÚ2024Äê»ù½ðÏîÄ¿ÉêÇë¹ý³ÌÖдæÔÚ³­Ï®ËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈÝÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®Ìõ£¬³·ÏúÌÆ½­²¨2024Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°·ÂÈË»úÆ÷ÈËÌý¾õÑо¿¡±£¨ÉêÇëºÅ6247014292£©ÉêÇ룬ȡÏûÌÆ½­²¨¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬¸øÓèÌÆ½­²¨Í¨±¨ÅúÆÀ¡£

£¨¶þÊ®£©¾­²é£¬ËÄ´¨Ä³¸ßУÕÅÔ˾ÕÔÚ2024Äê»ù½ðÏîÄ¿ÉêÇë¹ý³ÌÖдæÔÚ³­Ï®ËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈÝÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®Ìõ£¬³·ÏúÕÅÔ˾Õ2024Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°´óÆøÖÐCriegeeÖмäÌåÓëH2OºÍSO2·´Ó¦µÄÀíÂÛÑо¿¡±£¨ÉêÇëºÅ4247050434£©ÉêÇ룬ȡÏûÕÅÔ˾չú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬¸øÓèÕÅÔ˾Õͨ±¨ÅúÆÀ¡£

£¨¶þʮһ£©¾­²é£¬ÁÉÄþij¸ßУËÎÏþÐñÔÚ2024Äê»ù½ðÏîÄ¿ÉêÇë¹ý³ÌÖдæÔÚ³­Ï®ËûÈË»ù½ðÏîÄ¿ÉêÇëÊéÄÚÈÝÎÊÌâ¡£ÒÀ¾Ý¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¿ÆÑв»¶ËÐÐΪµ÷²é´¦Àí°ì·¨¡·µÚËÄÊ®Ìõ£¬³·ÏúËÎÏþÐñ2024Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡°»ùÓÚͼ½á¹¹¾ÛÀàÔöÁ¿µÄλÖÃ-Éç½»ÍøÂçȺÌå²éѯ¹Ø¼ü¼¼ÊõÑо¿¡±£¨ÉêÇëºÅ6247072686£©ÉêÇ룬ȡÏûËÎÏþÐñ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ÉêÇëºÍ²ÎÓëÉêÇë×ʸñ3Ä꣨2024Äê7ÔÂ19ÈÕÖÁ2027Äê7ÔÂ18ÈÕ£©£¬¸øÓèËÎÏþÐñͨ±¨ÅúÆÀ¡£

¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»á½«³ÖÐø¶Ô¿ÆÑ§»ù½ðÏîÄ¿ÉêÇë¡¢ÆÀÉó¡¢Ö´Ðм°³É¹û·¢±í¹ý³ÌÖз¢ÉúµÄ¿ÆÑв»¶ËÐÐΪ½øÐÐÑÏËà´¦Àí£¬Çë¹ã´ó¿Æ¼¼ÈËÔ±×Ô¾õ¼ùÐÐÐÂʱ´ú¿ÆÑ§¼Ò¾«Éñ£¬¼á³ÖÁ¼ºÃµÄѧ·ç×÷·ç£¬ã¡ÊØ¿ÆÑ§µÀµÂ×¼Ôò£»Çë¸÷ÒÀÍе¥Î»×Ô¾õÂÄÐÐÒÀÍе¥Î»Ö÷ÌåÔðÈΣ¬¼ÓÇ¿¿ÆÑгÏÐŽ¨É裬¹²Í¬¹¹½¨Á¼ºÃµÄѧÊõÉú̬¡£

×ªÔØÀ´Ô´£º¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»áÍøÕ¾

×ªÔØÀ´Ô´ÉùÃ÷£º±¾ÎÄÕÂ×ªÔØ×Ô¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»áÍøÕ¾£¬°æÈ¨¹éÔ­×÷Õß¼°Ô­ÍøÕ¾ËùÓС£±¾ÍøÕ¾²»¶Ô×ªÔØÎÄÕµÄ׼ȷÐÔ¡¢ºÏ·¨ÐÔ¸ºÔ𣬲éÔÄÈËÓ¦×ÔÐÐÅжÏÄÚÈÝÊÊÓÃÐÔ¡£×ªÔØ·ÇÉÌÒµÓÃ;£¬ÈçÀ´Ô´±ê×¢ÓÐÎó»òÇÖ·¸ÄúµÄÈ¨Òæ£¬ÇëÁªÏµÎÒÃÇ´¦Àí£¬ÎÒÃǽ«ÅäºÏɾ³ýÏà¹ØÄÚÈÝ¡£

 

Copyright ?°æÈ¨ËùÓУº¹ã¶«º£Ñó´óѧÉÌѧԺ
µØÖ·£º¹ã¶«Ê¡Ñô½­Êн­³ÇÇøÂÞÇÙ·1ºÅ
ÔÁICP±¸06058882ºÅ
  • ÉÌѧԺÕÐÉú×ÉѯȺ

ÓÊÕþ±àÂ룺529500
ÓÊÏ䣺gbs@taihepaimai.com
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿